Mandatory notification of intra group transfer of shares by primary insider’s related party
Nykode Therapeutics ASA (NYKD) · publisert 24. oktober 2022 kl. 17:58 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Einar Jørgen Greve via Cipriano AS | – | Annet Uklassifisert | 1 625 000 | 0 NOK | 24. oktober 2022 | NO0010714785 | outside of a trading venue |
Vedlegg
- Attachment Cipriano 221024.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, October 24, 2022 - Cipriano AS and Cipriano Invest AS, a 100% owned subsidiary of Cipriano AS, have merged. As a result, 1,625,000 shares in Nykode Therapeutics ASA have been transferred from Cipriano Invest AS to Cipriano AS. Cipriano AS is 100% owned by primary insider Einar J. Greve, Deputy Board Member of Nykode Therapeutics ASA.
Please see further details in attached document.